Skip to main content
. 2015 Nov 27;56(1):115–125. doi: 10.1093/geront/gnv663

Table 1.

Distributions of Risk Factors for Cognitive Decline by Veteran Status at Enrollment in the Women’s Health Initiative Memory Study

Non-Veteran (N = 7,051)
Mean (SD) or
N (%)
Veteran
(N = 279)
Mean (SD) or
N (%)
t test or chi-squared test
p value
Age 70.9 (3.8) 73.4 (3.8) p < .001
 Age range 65–80 65–80
Race/ethnicity (n = 3 missing)
 Asian 123 (1.7) 0 (0.0) p = .003
 African American 510 (7.2) 8 (2.9)
 Hispanic 172 (2.4) 3 (1.1)
 Non-Hispanic White 6,122 (86.8) 263 (94.3)
 Other 124 (1.8) 5 (1.8)
Education (n = 11 missing)
 Less than HS 548 (7.8) 6 (2.2) p < .001
 High school, GED 1,588 (22.6) 33 (11.8)
 Some college 2,822 (40.1) 126 (45.2)
 College graduate or higher 2,085 (29.6) 114 (40.9)
Marital status (n = 8 missing)
 Never married 227 (3.2) 16 (5.7) p = .03
 Divorced/separated 868 (12.3) 41 (14.7)
 Widowed 2,187 (31.1) 92 (33.0)
 Married/marriage-like relationship 3,756 (53.4) 130 (46.6)
Occupation (n = 210 missing)
 Managerial/professional 2,318 (33.8) 126 (46.2) p < .001
 Technical, sales, admin support 2,088 (30.5) 76 (27.8)
 Service/laborer 1,569 (22.9) 53 (19.4)
 Homemaker only 872 (12.7) 18 (6.6)
Employment status (n = 18 missing)
 Not working 5,783 (82.2) 240 (86.3) p = .08
 Employed 1,251 (17.1) 38 (13.7)
Cardiovascular disease burden
 Cardiovascular disease (n = 109 missing) 1,210 (17.4) 52 (19.0) p = .51
 Angina (n = 65 missing) 511 (7.3) 30 (10.9) p = .03
 Peripheral arterial disease (n = 58 missing) 149 (2.1) 9 (3.2) p = .21
 Coronary revascularization (n = 132 missing) 179 (2.6) 9 (3.3) p = .47
 Stroke 110 (1.6) 9 (3.2) p = .03
Cardiovascular disease risk factors
 Hypertension 2,738 (39.3) 122 (44.5) p = .08
 Diabetes 515 (7.3) 16 (5.7) p = .32
Smoking (miss = 107)
 Never 3,709 (53.4) 122 (44.7) p = .02
 Former 2,740 (39.4) 130 (47.6)
 Current 501 (7.2) 21 (7.7)
Body mass index 28.5 (5.7) 28.0 (5.5) p = .13
Current alcohol consumption (miss = 17)
 None 3,276 (46.6) 113 (40.8) p = 0.15
 <1/day 2,922 (41.5) 125 (45.1)
 ≥1/day 838 (11.9) 39 (14.1)
HT treatment assignment p = .53
 CEE-Alone placebo 1,395 (19.8) 62 (22.2)
 CEE-Alone 1,383 (19.6) 47 (16.8)
 CEE + MPA placebo 2,167 (30.7) 90 (32.3)
 CEE + MPA 2,106 (29.9) 80 (28.7)
Unadjusted 3MSE score 95.20 (4.33) 95.51 (3.54) p = .23

Note: GED = general educational development; HT = hormone therapy; CEE = conjugated equine estrogens; MPA = medroxyprogesertone acetate; 3MSE = Modified Mini-Mental State Exam.